The pooled MD indicated a reduction in worm burden in the Moxi-Doxy group (MD = −6.41, 95% CI: 13.52 to 0.69; I 2 = 98.28%; CoE: low), although this difference did not reach statistical significance ( P = 0.08) ( Fig. 4 ). 3.6.
← all excerpts
A systematic review and meta-analysis of non-arsenical adulticide protocols using moxidectin and doxycycline for the treatment of adult heartworm infection in dogs.
1
0.0800
0.0800